Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/13/2001 | CA2410158A1 Protein markers for pharmaceuticals and related toxicity |
12/13/2001 | CA2410052A1 Delivery systems for bioactive agents |
12/13/2001 | CA2410010A1 Algorithmic determination of connectrons |
12/13/2001 | CA2409392A1 Intracellular signaling proteins |
12/13/2001 | CA2409342A1 Extracellular messengers |
12/13/2001 | CA2408748A1 Nuclear hormone receptor |
12/13/2001 | CA2407551A1 Cis-zeatin glucosyl transferase from zea mays |
12/13/2001 | CA2398087A1 Novel human enzymes and polynucleotides encoding the same |
12/13/2001 | CA2381249A1 Methods and compositions for modulating oxidized ldl transport |
12/12/2001 | EP1162458A1 Methods and compositions for modulating oxidized LDL transport |
12/12/2001 | EP1162278A2 Isometric primer extension method and kit for detection and quantification of specific nucleic acid |
12/12/2001 | EP1162277A2 Probes and methods for detection of nucleic acids |
12/12/2001 | EP1162276A2 MRNA molecules to be used as indicators of the functional and activational state of T-lymphocytes |
12/12/2001 | EP1162275A1 METHOD FOR LARGE SCALE cDNA CLONING AND SEQUENCING BY CIRCULATING SUBTRACTION |
12/12/2001 | EP1162273A1 Recombinant DNA vectors for gene therapy |
12/12/2001 | EP1162272A2 Generation of immune responses to prostate-specific antigen (SPA) |
12/12/2001 | EP1162271A2 Method for controlling the gene expression in lactic acid bacteria |
12/12/2001 | EP1162270A2 Phagemids coexpressing a surface receptor and a surface heterologous protein |
12/12/2001 | EP1162269A1 Novel polypeptide |
12/12/2001 | EP1162268A2 Cytochrome P450 monooxygenase and NADPH cytochrome P450 oxidoreductase genes and proteins related to the omega hydroxylase complex of Candida tropicalis and methods relating thereto |
12/12/2001 | EP1162267A2 Plant virus vector, plasmid, process for expression of foreign gene and process for obtaining foreign gene product |
12/12/2001 | EP1162266A2 DNA fragments of the methylotrophic pichia pastoris yeast ICL gene |
12/12/2001 | EP1162265A2 Human PEM as a target for fertility control and Alzheimer therapy |
12/12/2001 | EP1162264A2 Chimeric hormone receptor |
12/12/2001 | EP1162263A1 Nucleozymes |
12/12/2001 | EP1162262A1 Fibers having nucleic acid immobilized thereon, alignment of fibers having nucleic acid immobilized thereon and slice thereof |
12/12/2001 | EP1162206A2 Peptide nucleic acids |
12/12/2001 | EP1161957A1 Complex for transferring an anionic substance of interest into a cell |
12/12/2001 | EP1161862A2 See-through medaka |
12/12/2001 | EP1161681A2 Use of lna in mass spectrometry |
12/12/2001 | EP1161563A2 Probe/mobility modifier complexes for multiplex nucleic acid detection |
12/12/2001 | EP1161562A1 Deleted sequences in m. bovis bcg/m. bovis or m. tuberculosis, method for detecting mycobacteria using said sequences and vaccines |
12/12/2001 | EP1161561A1 One step sample preparation and detection of nucleic acids in complex biological samples |
12/12/2001 | EP1161560A1 Electropolymerizable film, and method of making and use thereof |
12/12/2001 | EP1161558A1 Intact cell assay for protein tyrosine phosphatases |
12/12/2001 | EP1161554A2 Detection of mutations in genes by specific lna primers |
12/12/2001 | EP1161551A2 Methods and materials for the rapid and high volume production of a gene knock-out library in an organism |
12/12/2001 | EP1161550A1 Target cell-specific, multivalent proteins (mvp) |
12/12/2001 | EP1161549A2 Retrovirus producing cells utilizing a high multiplicity of transduction |
12/12/2001 | EP1161548A2 Recombinant protein production in a human cell using sequences encoding adenovirus e1 protein |
12/12/2001 | EP1161547A1 Intravascular delivery of non-viral nucleic acid |
12/12/2001 | EP1161546A2 Trans-species transfer of apoptotic genes and transgenic plants developed thereby |
12/12/2001 | EP1161545A1 Methods of using viral replicase |
12/12/2001 | EP1161544A1 Generation of conditional yeast mutants, methods and reagents related thereto |
12/12/2001 | EP1161543A1 Metalloprotease polynucleotides and polypeptides |
12/12/2001 | EP1161542A1 Polysaturated fatty acid (pufa) elongase from caenorhabditis elegans |
12/12/2001 | EP1161541A1 Method of modifying plant morphology, biochemistry or physiology using cdc25 substrates |
12/12/2001 | EP1161540A1 Genetic manipulation of isoflavonoids |
12/12/2001 | EP1161538A2 Method for inducing viral resistance into a plant |
12/12/2001 | EP1161537A1 Non-spreading pestivirus |
12/12/2001 | EP1161536A1 Human proteins having hydrophobic domains and dnas encoding these proteins |
12/12/2001 | EP1161535A1 Rna polymerase i transcription factor tif-ia |
12/12/2001 | EP1161534A1 Differential expression of organellar gene products |
12/12/2001 | EP1161533A1 Expression of human alpha-fetoprotein in mammalian cells |
12/12/2001 | EP1161532A1 Human serpin proteins |
12/12/2001 | EP1161531A1 Tumor-associated antigen |
12/12/2001 | EP1161530A1 Protein for blocking platelet adhesion |
12/12/2001 | EP1161529A2 End selection in directed evolution |
12/12/2001 | EP1161528A1 Methods and reagents for identifying synthetic genetic elements |
12/12/2001 | EP1161527A1 Improved expression vector for consistent cellular expression of the tet on repressor in multiple cell types |
12/12/2001 | EP1161526A2 Trait-associated gene identification method |
12/12/2001 | EP1161525A2 Methods and compositions for regulating memory consolidation |
12/12/2001 | EP1161522A1 Method of isolating cd8+ cells, and related hybridoma cells, antibodies and polypeptides |
12/12/2001 | EP1161456A2 Antibody and chemokine constructs and their use for treating autoimmune diseases |
12/12/2001 | EP1161455A1 A novel chimeric protein for prevention and treatment of hiv infection |
12/12/2001 | EP1161454A2 Peptides with anti-angiogenic activity |
12/12/2001 | EP1161450A1 Bone stimulating factor |
12/12/2001 | EP1161448A1 49 human secreted proteins |
12/12/2001 | EP1161447A1 50 human secreted proteins |
12/12/2001 | EP1161446A1 50 human secreted proteins |
12/12/2001 | EP1161445A2 Human dickkopf-related protein and nucleic acid molecules and uses therefor |
12/12/2001 | EP1161444A1 A novel inhibitor of programmed cell death |
12/12/2001 | EP1161442A2 Exocytosis pathway proteins and methods of use |
12/12/2001 | EP1161439A1 Xylo-lna analogues |
12/12/2001 | EP1161266A1 Matriptase, a serine protease and its applications |
12/12/2001 | EP1161261A1 Apoptosis inducing molecule ii and methods of use |
12/12/2001 | EP1161227A2 Microparticles for delivery of nucleic acid |
12/12/2001 | EP1161147A1 Peptide mimics useful for treating disease |
12/12/2001 | EP1161144A1 Cryopreservation of oocytes and embryos and methods for producing animals involving the same |
12/12/2001 | EP1161136A2 INTERSPECIFIC $i(NICOTIANA) HYBRIDS AND THEIR PROGENY |
12/12/2001 | EP1151156A4 Luciferase reporter bioassay of parathyroid hormone compounds |
12/12/2001 | EP1056884B1 Method for the non-specific amplification of nucleic acid |
12/12/2001 | EP1017709A4 G-protein coupled glycoprotein hormone receptor aomf05 |
12/12/2001 | EP1015494A4 Catalytic antibodies and a method of producing same |
12/12/2001 | EP0809656B1 MONOCLONAL ANTIBODY SPECIFIC FOR beta-A4 PEPTIDE |
12/12/2001 | EP0787144B1 Major outer membrane protein cd of moraxella |
12/12/2001 | EP0783586B1 An attenuated vaccination and gene-transfer virus, a method to make the virus and a pharmaceutical composition comprising the virus |
12/12/2001 | EP0743950B1 Process for separating double-stranded/single-stranded nucleic acid structures |
12/12/2001 | EP0733712B1 Process for producing substance |
12/12/2001 | EP0695353B1 Selecting genes encoding catalytic antibodies |
12/12/2001 | EP0651808B1 Recombinant dna encoding a desulfurization biocatalyst |
12/12/2001 | EP0522159B1 Antibody to pituitary adenylate cyclase activating peptide-pacap, hybridoma and assay for pacap |
12/12/2001 | EP0522091B1 Use of a mbp peptide for the preparation of a medicament for the treatment of multiple sclerosis |
12/12/2001 | CN1326513A Process for enzymatically modifying pectin |
12/12/2001 | CN1326511A Systemic viral/ligand gene delivery system and gene therapy |
12/12/2001 | CN1326510A Methods for producing denetically modified plants, plant materials and plant products produced thereby |
12/12/2001 | CN1326509A MOraxella catarrhalis ABSB034 polypeptides and uses thereof |
12/12/2001 | CN1326508A Polynucleotides and polypeptides BASB033 from neisseria meningitidis and their uses |
12/12/2001 | CN1326507A Promoters for gene expression in roots of plants |
12/12/2001 | CN1326506A Use of specific hybrid promoters for controlling tissue expression |